These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 33826972)
1. Bioactive half-sandwich Rh and Ir bipyridyl complexes containing artemisinin. Chellan P; Avery VM; Duffy S; Land KM; Tam CC; Kim JH; Cheng LW; Romero-Canelón I; Sadler PJ J Inorg Biochem; 2021 Jun; 219():111408. PubMed ID: 33826972 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of new polynuclear organometallic Ru(II), Rh(III) and Ir(III) pyridyl ester complexes as in vitro antiparasitic and antitumor agents. Chellan P; Land KM; Shokar A; Au A; An SH; Taylor D; Smith PJ; Riedel T; Dyson PJ; Chibale K; Smith GS Dalton Trans; 2014 Jan; 43(2):513-26. PubMed ID: 24121555 [TBL] [Abstract][Full Text] [Related]
3. Improved antiparasitic activity by incorporation of organosilane entities into half-sandwich ruthenium(II) and rhodium(III) thiosemicarbazone complexes. Adams M; de Kock C; Smith PJ; Land KM; Liu N; Hopper M; Hsiao A; Burgoyne AR; Stringer T; Meyer M; Wiesner L; Chibale K; Smith GS Dalton Trans; 2015 Feb; 44(5):2456-68. PubMed ID: 25559246 [TBL] [Abstract][Full Text] [Related]
4. Pentamethylcyclopentadienyl-rhodium and iridium complexes containing (N^N and N^O) bound chloroquine analogue ligands: synthesis, characterization and antimalarial properties. Ekengard E; Kumar K; Fogeron T; de Kock C; Smith PJ; Haukka M; Monari M; Nordlander E Dalton Trans; 2016 Mar; 45(9):3905-17. PubMed ID: 26829897 [TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship studies of antiplasmodial cyclometallated ruthenium(II), rhodium(III) and iridium(III) complexes of 2-phenylbenzimidazoles. Rylands LI; Welsh A; Maepa K; Stringer T; Taylor D; Chibale K; Smith GS Eur J Med Chem; 2019 Jan; 161():11-21. PubMed ID: 30342422 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, molecular structure, computational study and in vitro anticancer activity of dinuclear thiolato-bridged pentamethylcyclopentadienyl Rh(III) and Ir(III) complexes. Gupta G; Garci A; Murray BS; Dyson PJ; Fabre G; Trouillas P; Giannini F; Furrer J; Süss-Fink G; Therrien B Dalton Trans; 2013 Nov; 42(43):15457-63. PubMed ID: 24022745 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of new salicylaldehyde-2-picolinylhydrazone Schiff base compounds of Ru(II), Rh(III) and Ir(III) as in vitro antitumor, antibacterial and fluorescence imaging agents. Palepu NR; Nongbri SL; Premkumar JR; Verma AK; Bhattacharjee K; Joshi SR; Forbes S; Mozharivskyj Y; Thounaojam R; Aguan K; Kollipara MR J Biol Inorg Chem; 2015 Jun; 20(4):619-38. PubMed ID: 25712889 [TBL] [Abstract][Full Text] [Related]
8. Antimicrobial evaluation of neutral and cationic iridium(III) and rhodium(III) aminoquinoline-benzimidazole hybrid complexes. Baartzes N; Jordaan A; Warner DF; Combrinck J; Taylor D; Chibale K; Smith GS Eur J Med Chem; 2020 Nov; 206():112694. PubMed ID: 32861176 [TBL] [Abstract][Full Text] [Related]
9. Thiabendazole-based Rh(III) and Ir(III) biscyclometallated complexes with mitochondria-targeted anticancer activity and metal-sensitive photodynamic activity. Pérez-Arnaiz C; Acuña MI; Busto N; Echevarría I; Martínez-Alonso M; Espino G; García B; Domínguez F Eur J Med Chem; 2018 Sep; 157():279-293. PubMed ID: 30099251 [TBL] [Abstract][Full Text] [Related]